Molina Healthcare Files 8-K

TL;DR

Molina Healthcare filed a standard 8-K, no major news.

AI Summary

Molina Healthcare, Inc. filed an 8-K on November 17, 2025, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for this date.

Why It Matters

This 8-K filing serves as a routine update and confirmation of reporting requirements for Molina Healthcare, Inc. with the SEC.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report and does not disclose any new material information or events that would inherently increase risk.

Key Players & Entities

• MOLINA HEALTHCARE, INC. (company) — Registrant
• 200 Oceangate, Suite 100, Long Beach, California 90802 (location) — Principal executive offices address
• November 17, 2025 (date) — Date of report

FAQ

Key Financial Figures

• $0.001 — ge on which registered Common Stock , $0.001 Par Value MOH New York Stock Exchan
• $750 million — subject to market and other conditions, $750 million aggregate principal amount of senior no

Filing Documents

• moh20251116_8k.htm (8-K) — 92KB
• ex_889369.htm (EX-99.1) — 9KB
• logom.jpg (GRAPHIC) — 5KB
• 0001437749-25-035305.txt ( ) — 248KB
• moh-20251117.xsd (EX-101.SCH) — 3KB
• moh-20251117_def.xml (EX-101.DEF) — 12KB
• moh-20251117_lab.xml (EX-101.LAB) — 15KB
• moh-20251117_pre.xml (EX-101.PRE) — 12KB
• moh20251116_8k_htm.xml (XML) — 3KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. Note: The information furnished herewith pursuant to Item 7.01 of this Current Report on Form 8-K (this "Report") shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed by Molina Healthcare, Inc. (the "Company") under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. The furnishing of this Report is not intended to constitute a determination by the Company that the information is material or that dissemination of the information is required by Regulation FD. Announcement of Senior Notes Offering and New Credit Facility On November 17, 2025, the Company issued a press release announcing it intends to privately offer (the "Offering"), subject to market and other conditions, $750 million aggregate principal amount of senior notes due 2031 (the "Notes"). The Notes are to be offered and sold only to persons reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act, and to certain non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act. The Company intends to use the net proceeds from the Offering to repay the Company's outstanding delayed draw term loans (the "Term Loans") under the credit agreement governing the Company's existing credit facility (the "Existing Credit Facility"). The Company also announced that it intends, following such repayment, to terminate the Existing Credit Facility and replace it with a new revolving credit facility (the "New Credit Facility"). The New Credit Facility is expected to contain terms and conditions substantially similar to those contained in the Existing Credit

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 99.1 Press release of Molina Healthcare, Inc. issued November 17, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. MOLINA HEALTHCARE, INC. Date: November 17, 2025 By: /s/ Jeff Barlow Jeff Barlow Chief Legal Officer and Secretary -5-

View Full Filing

View this 8-K filing on SEC EDGAR